Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Argan (AGX) Common Equity: 2010-2025

Historic Common Equity for Argan (AGX) over the last 16 years, with Jan 2025 value amounting to $351.9 million.

  • Argan's Common Equity rose 27.69% to $419.7 million in Q4 2025 from the same period last year, while for Oct 2025 it was $419.7 million, marking a year-over-year increase of 27.69%. This contributed to the annual value of $351.9 million for FY2025, which is 20.94% up from last year.
  • According to the latest figures from FY2025, Argan's Common Equity is $351.9 million, which was up 20.94% from $290.9 million recorded in FY2024.
  • Argan's 5-year Common Equity high stood at $351.9 million for FY2025, and its period low was $280.9 million during FY2023.
  • Its 3-year average for Common Equity is $307.9 million, with a median of $290.9 million in 2024.
  • As far as peak fluctuations go, Argan's Common Equity dropped by 13.73% in 2023, and later increased by 20.94% in 2025.
  • Yearly analysis of 5 years shows Argan's Common Equity stood at $322.4 million in 2021, then increased by 0.99% to $325.6 million in 2022, then declined by 13.73% to $280.9 million in 2023, then climbed by 3.57% to $290.9 million in 2024, then rose by 20.94% to $351.9 million in 2025.